Vigilare Wealth Management Invitae Corp Transaction History

Vigilare Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$1.2 - $2.73 $13,434 - $30,562	11,195 New	11,195 $15,000
Q3 2022 Oct 20, 2022	BUY	$1.9 - $8.63 $23,009 - $104,509	12,110 New	12,110 $30,000
Q1 2022 Apr 06, 2022	SELL	$6.28 - $15.59 $227,461 - $564,669	-36,220 Closed	0 $0
Q4 2021 Jan 07, 2022	BUY	$14.7 - $28.67 $234,171 - $456,713	15,930 Added 78.51%	36,220 $553,000
Q3 2021 Oct 19, 2021	BUY	$24.31 - $33.6 $135,285 - $186,984	5,565 Added 37.79%	20,290 $577,000

Q2 2021 Jul 16, 2021	BUY	$26.09 - $40.4 $384,175 - $594,890	14,725 New	14,725 $497,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.